Pediatric Neurology Briefs (Aug 2002)

Nonstimulant Therapy for ADHD

  • J Gordon Millichap

DOI
https://doi.org/10.15844/pedneurbriefs-16-8-11
Journal volume & issue
Vol. 16, no. 8
pp. 63 – 63

Abstract

Read online

The results of a multicenter, open-label, dose-titration study of GW320659, a novel norepinephrine and dopamine reuptake inhibitor, are reported from GlaxoSmithKline, Research Triangle Park, NC.

Keywords